NO20072873L - Tri(hydroksymetyl)metylaminsalt eller et etanolaminsalt av (2S)-2-etoksy-3-(4-(2-(heksyl(2-fenyletyl)amino)-2-oksoetoksy)fenyl)propansyre - Google Patents
Tri(hydroksymetyl)metylaminsalt eller et etanolaminsalt av (2S)-2-etoksy-3-(4-(2-(heksyl(2-fenyletyl)amino)-2-oksoetoksy)fenyl)propansyreInfo
- Publication number
- NO20072873L NO20072873L NO20072873A NO20072873A NO20072873L NO 20072873 L NO20072873 L NO 20072873L NO 20072873 A NO20072873 A NO 20072873A NO 20072873 A NO20072873 A NO 20072873A NO 20072873 L NO20072873 L NO 20072873L
- Authority
- NO
- Norway
- Prior art keywords
- salt
- oxoethoxy
- phenylethyl
- ethoxy
- hexyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0403072A SE0403072D0 (sv) | 2004-12-16 | 2004-12-16 | Pharmaceutically useful salts of carboxylic acid derivates |
| PCT/SE2005/001916 WO2006065214A1 (en) | 2004-12-16 | 2005-12-14 | Tri (hydroxymethyl) methylamine salt or an ethanol amine salt of (2s) -2-ethoxy-3- (4-{2- [hexyl (2- phenylethyl) amino] - 2 -oxoethoxy} phenyl) propanoic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20072873L true NO20072873L (no) | 2007-06-21 |
Family
ID=34075233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20072873A NO20072873L (no) | 2004-12-16 | 2007-06-06 | Tri(hydroksymetyl)metylaminsalt eller et etanolaminsalt av (2S)-2-etoksy-3-(4-(2-(heksyl(2-fenyletyl)amino)-2-oksoetoksy)fenyl)propansyre |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20080114064A1 (zh) |
| EP (1) | EP1831151A4 (zh) |
| JP (1) | JP2008524209A (zh) |
| KR (1) | KR20070087122A (zh) |
| CN (1) | CN101080383A (zh) |
| AR (1) | AR055006A1 (zh) |
| AU (1) | AU2005317285A1 (zh) |
| BR (1) | BRPI0519029A2 (zh) |
| CA (1) | CA2589519A1 (zh) |
| IL (1) | IL183529A0 (zh) |
| MX (1) | MX2007007209A (zh) |
| NO (1) | NO20072873L (zh) |
| RU (1) | RU2007126748A (zh) |
| SE (1) | SE0403072D0 (zh) |
| TW (1) | TW200635879A (zh) |
| WO (1) | WO2006065214A1 (zh) |
| ZA (1) | ZA200705069B (zh) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0104334D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| GB0314129D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
-
2004
- 2004-12-16 SE SE0403072A patent/SE0403072D0/sv unknown
-
2005
- 2005-12-12 AR ARP050105196A patent/AR055006A1/es not_active Application Discontinuation
- 2005-12-14 CA CA002589519A patent/CA2589519A1/en not_active Abandoned
- 2005-12-14 KR KR1020077016297A patent/KR20070087122A/ko not_active Application Discontinuation
- 2005-12-14 WO PCT/SE2005/001916 patent/WO2006065214A1/en active Application Filing
- 2005-12-14 AU AU2005317285A patent/AU2005317285A1/en not_active Abandoned
- 2005-12-14 BR BRPI0519029-0A patent/BRPI0519029A2/pt not_active Application Discontinuation
- 2005-12-14 US US11/721,698 patent/US20080114064A1/en not_active Abandoned
- 2005-12-14 MX MX2007007209A patent/MX2007007209A/es not_active Application Discontinuation
- 2005-12-14 JP JP2007546608A patent/JP2008524209A/ja active Pending
- 2005-12-14 CN CNA2005800432907A patent/CN101080383A/zh active Pending
- 2005-12-14 EP EP05819085A patent/EP1831151A4/en not_active Withdrawn
- 2005-12-14 RU RU2007126748/04A patent/RU2007126748A/ru not_active Application Discontinuation
- 2005-12-16 TW TW094144610A patent/TW200635879A/zh unknown
-
2007
- 2007-05-29 IL IL183529A patent/IL183529A0/en unknown
- 2007-06-06 NO NO20072873A patent/NO20072873L/no not_active Application Discontinuation
- 2007-06-12 ZA ZA200705069A patent/ZA200705069B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200705069B (en) | 2008-10-29 |
| TW200635879A (en) | 2006-10-16 |
| MX2007007209A (es) | 2007-08-15 |
| WO2006065214A1 (en) | 2006-06-22 |
| EP1831151A4 (en) | 2010-06-30 |
| AR055006A1 (es) | 2007-08-01 |
| IL183529A0 (en) | 2007-09-20 |
| KR20070087122A (ko) | 2007-08-27 |
| SE0403072D0 (sv) | 2004-12-16 |
| EP1831151A1 (en) | 2007-09-12 |
| BRPI0519029A2 (pt) | 2008-12-23 |
| JP2008524209A (ja) | 2008-07-10 |
| CN101080383A (zh) | 2007-11-28 |
| AU2005317285A1 (en) | 2006-06-22 |
| CA2589519A1 (en) | 2006-06-22 |
| RU2007126748A (ru) | 2009-01-27 |
| US20080114064A1 (en) | 2008-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119784T1 (el) | Ακετυλιωμενες σαλικυλικες ενωσεις λιπαρου οξεος και οι χρησεις αυτων | |
| RS54445B1 (en) | 3,5-DIAMINO-6-CHLORO-N- (N- (4- (4- (2- (HEXYL (2,3,4,5,6-PENTAHYDROXYHEXYL) AMINO) ETHOXY) PHENYL) BUTYL) CARBAMIMIDOIL) PYRAZINE -2-CARBOXAMIDE | |
| PE20081372A1 (es) | COMPOSICION FARMACEUTICA QUE COMPRENDE 2-[4-(7-ETIL-5H-PIRROLO[2,3-b]PIRAZIN-6-IL)-FENIL]-PROPAN-2-OL COMO INHIBIDOR DE QUINASA | |
| CY1108445T1 (el) | Νεα μεθοδος συνθεσης και νεα κρυσταλλικη μορφη της αγομελατινης καθως και φαρμακευτικες συνθεσεις που την περιεχουν | |
| DK2091948T3 (da) | Nye inhibitorer af glutaminylcyclase | |
| UY31553A1 (es) | Derivados herbicidas de piridazinona | |
| CY1113011T1 (el) | Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην | |
| EA200970569A1 (ru) | Применимые в качестве гербицидных соединений пиридопиразиновые производные | |
| CY1112102T1 (el) | Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1 | |
| CY1114637T1 (el) | 4-[4-({[4-χλωρο-3-(τριφθορομεθυλο)φαινυλο)]καρβαμοϋλ}αμινο)-3-φθοροφαινοξυ]-ν-μεθυλοπυριδινο-2-καρβοξαμιδιο μονοϋδρικο | |
| EA201070698A1 (ru) | Твердые формы 3-(6-(1-(2,2-дифторбензо[d][1,3]-диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты | |
| EA200702614A1 (ru) | Способы получения 4-(бифенилил)азетидин-2-оналкилфосфиновых кислот | |
| CY1111269T1 (el) | Ρυθμιστες βενζιμιδαζολης του vr1 | |
| CY1116168T1 (el) | Συγκρυσταλλοι και αλατα αναστολεων toy ccr3 | |
| CY1112829T1 (el) | Νεα μεθοδος συνθεσης για την αγομελατινη | |
| DK1910267T3 (da) | Fremgangsmåde til fremstilling af carboxylsyrealkylestere | |
| EA201071269A1 (ru) | 3,4-замещенные пиперидиновые производные в качестве ингибиторов ренина | |
| EA200970124A1 (ru) | Производные 2-арилиндола в качестве ингибиторов npges-1 | |
| ATE520651T1 (de) | Substituierte phenylmethylbicyclocarbonsäureamidverbindungen | |
| EA201390481A1 (ru) | Кристаллические оксалатные соли диамидного соединения | |
| CY1115094T1 (el) | Νεα μεθοδος για την συνθεση (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στην συνθεση αγομελατινης | |
| UY30787A1 (es) | "inhibidores benzoimidazolicos de trpv1" | |
| CY1111010T1 (el) | Ενωσεις τετραϋδρο-ναφθαλενο-1-καρβοξυλικου οξεος υποκατεστημενου με πιπεριδινη ή πιπεραζινη που αναστελλουν την mtp | |
| JP2011515498A5 (zh) | ||
| EA200600760A1 (ru) | Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |